MedTrace Logo

A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis

NCT02287610 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2024-12-18

Study results available
· View outcomes & findings →

Summary

The overall objective of the study is to assess the effectiveness of switching from immediate-release prednisone (conventional) therapy to delayed-release prednisone (RAYOS) in patients with moderately to severely active Rheumatoid Arthritis (RA), managed according to standard of care in clinical practice settings.

Conditions

Interventions

DRUG

RAYOS (delayed-release prednisone)

Physicians may prescribe any dosage of RAYOS based on what is appropriate for the treatment of the patient's condition as determined by performing standard of care assessments.

Sponsors & Collaborators

Principal Investigators

  • MD · Amgen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-10-31
Completion
2015-10-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02287610 on ClinicalTrials.gov